000 01630 a2200493 4500
005 20250513175213.0
264 0 _c19990819
008 199908s 0 0 eng d
022 _a0272-457X
024 7 _a10.1089/hyb.1999.18.69
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaurer-Gebhard, M
245 0 0 _aA novel animal model for the evaluation of the efficacy of drugs directed against the ErbB2 receptor on metastasis formation.
_h[electronic resource]
260 _bHybridoma
_cFeb 1999
300 _a69-75 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Renal Cell
_ximmunology
650 0 4 _aDisease Models, Animal
650 0 4 _aErbB Receptors
_ximmunology
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aHumans
650 0 4 _aImmunocompetence
650 0 4 _aImmunohistochemistry
650 0 4 _aImmunotoxins
_xtherapeutic use
650 0 4 _aKidney Neoplasms
_ximmunology
650 0 4 _aLac Operon
650 0 4 _aLung
_xpathology
650 0 4 _aLung Neoplasms
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNeoplasm Metastasis
_xprevention & control
650 0 4 _aNeoplasm Transplantation
650 0 4 _aReceptor, ErbB-2
_xantagonists & inhibitors
650 0 4 _aTransfection
650 0 4 _aTumor Cells, Cultured
700 1 _aSchmidt, M
700 1 _aAzemar, M
700 1 _aStöcklin, E
700 1 _aWels, W
700 1 _aGroner, B
773 0 _tHybridoma
_gvol. 18
_gno. 1
_gp. 69-75
856 4 0 _uhttps://doi.org/10.1089/hyb.1999.18.69
_zAvailable from publisher's website
999 _c10171028
_d10171028